Please login to the form below

Not currently logged in


This page shows the latest achondroplasia news and features for those working in and with pharma, biotech and healthcare.

BioMarin drug boosts growth in children with dwarfism

BioMarin drug boosts growth in children with dwarfism

The small study in children with achondroplasia - the most common form of dwarfism - showed that children treated with the highest dose of BMN 111 (vosoritide) grew 6cm in six months, while ... The results suggest vosoritide could a new treatment option

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Cuttsy + Cuttsy

How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...